Concepedia

Oliver Van Oekelen

OV

Statistics

Publications

21

Citations

3.6K

H-Index

16

Active since

2018

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of Oxford

Tisch Hospital

Nuffield Orthopaedic Centre

Bristol-Myers Squibb (Germany)

Oliver Van Oekelen is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, multiple myeloma, and multiple myeloma therapy.

ORCID

Publications per year

2018–2024

21

Publications

21

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane M. Del Valle, Seunghee Kim‐Schulze, Hsin-Hui Huang et al. · Nature Medicine · 2020 · 2.7K citations · Full text

, , +14

Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy

Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya et al. · Nature Medicine · 2021 · 256 citations · Full text

, , +14

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine et al. · Journal of Hematology & Oncology · 2020 · 142 citations · Full text

, , +17

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine et al. · Blood · 2022 · 103 citations · Full text

, , +15

An inflammatory cytokine signature helps predict COVID-19 severity and death

Diane M. Del Valle, Seunghee Kim‐Schulze, Huang Hsin-hui et al. · medRxiv · 2020 · 96 citations · Full text

, , +17

1–5 of 21